Patient Name : Ms.

RINKI DEY Collected : 30/Jun/2023 07:29AM

Age/Gender : 31 Y 3 M 10 D /F Received : 30/Jun/2023 01:06PM
UHID/MR No : DPTI.0000002160 Reported : 30/Jun/2023 01:57PM
Visit ID : DSDYOPV1187 Status : Final Report
Ref Doctor : DR RUPASHREE DASGUPTA Client Name : PUP 24X7_CREDIT
IP/OP NO : Patient location : UTTAR PALLY,Kolkata

DEPARTMENT OF IMMUNOLOGY

Test Name Result Status Unit Bio. Ref. Range Method

THYROID PROFILE FREE (FT3, FT4, TSH) , SERUM
FREE T3 (FT3) 3.35 Normal pg/mL 2.5-3.9 CLIA
FREE T4 (FT4) 0.88 Normal ng/dL 0.61-1.12 CLIA
THYROID STIMULATING 2.340 Normal µIU/mL 0.38-5.33 CLIA
HORMONE (TSH)
Comment:
Elevated concentrations of FT3 occur in Grave’s disease and most other classical causes of hyperthyroidism.Decreased
concentrations occur in primary hypothyroid diseases such as Hashimoto thyroiditis and neonatal hypothyroidism or secondary
hypothyroidism due to defects at the hypothalamohypophyseal level. It may decrease by ≤25% in healthy older persons while FT4
remains normal.
FT4 gives corrected values in patients in whom the total T4 is altered on account of changes in serum proteins or in binding
sites.Monitoring restoration to normal range is the only laboratory criterion to estimate appropriate replacement dose of
levothyroxine because 6–8 weeks are required before TSH reflects these changes. FT4 assays are prone to inaccurate readings in
pregnant women. Anticonvulsant drug therapy (particularly phenytoin) may result in decreased FT4 levels due to an increased
hepatic metabolism and secondarily to displacement of hormone from binding sites.

Serum TSH concentrations exhibit a diurnal variation with the peak occurring during the night and the nadir occurring between 10
a.m. and 4 p.m.In primary hypothyroidism, thyroid-stimulating hormone (TSH) levels will be elevated. In primary hyperthyroidism,
TSH levels will be low. Elevated or low TSH in the context of normal free thyroxine is often referred to as subclinical hypo- or
hyperthyroidism, respectively.
Note:
Bio Ref Range for TSH in
For Pregnant Females
uIU/mL
First trimester 0.1 - 2.5
Second trimester 0.2 – 3.0
Third trimester 0.3 – 3.0

Page 1 of 4

SIN No:IM05726412
Patient Name : Ms.RINKI DEY Collected : 30/Jun/2023 07:29AM
Age/Gender : 31 Y 3 M 10 D /F Received : 30/Jun/2023 01:06PM
UHID/MR No : DPTI.0000002160 Reported : 30/Jun/2023 02:20PM
Visit ID : DSDYOPV1187 Status : Final Report
Ref Doctor : DR RUPASHREE DASGUPTA Client Name : PUP 24X7_CREDIT
IP/OP NO : Patient location : UTTAR PALLY,Kolkata

DEPARTMENT OF IMMUNOLOGY

Test Name Result Status Unit Bio. Ref. Range Method

PROLACTIN , SERUM 60.46 ng/mL CLIA

Comment:
REFERENCE GROUP REFERENCE RANGE IN ng/ml
ADULT FEMALES
PRE-MENOPAUSAL 3.3 – 26.7
PREGNANCY 9.7 – 208.5
POST MENOPAUSAL 2.7 – 19.6
MALES 2.6 – 13.1

Normal prolactin secretion varies with time, which results in serum prolactin levels two to three times higher at night than during the
day.
Serum prolactin levels during the menstrual cycle are variable and commonly exhibit slight elevations during the mid-cycle.
Prolactin levels in normal individuals tend to rise in response to physiologic stimuli including sleep, exercise, nipple stimulation,
sexual intercourse, hypoglycemia, pregnancy, and surgical stress.
Prolactin values that exceed the reference values may be due to macroprolactin (prolactin bound to immunoglobulin).
Macroprolactin should be evaluated if signs and symptoms of hyperprolactinemia are absent or pituitary imaging studies are not
informative.
Increased levels of prolactin upto 100ng/mL are documented with the use of following drugs: Neuroleptics, antidepressants,
antipsychotics, medications for nausea such as metoclopramide, birth control pills, estrogen analogs, dopamine antagonists, some
blood pressure medications like methyldopa, reserpine, and opiates.

Page 2 of 4

SIN No:IM05726412
Patient Name : Ms.RINKI DEY Collected : 30/Jun/2023 07:29AM
Age/Gender : 31 Y 3 M 10 D /F Received : 30/Jun/2023 01:06PM
UHID/MR No : DPTI.0000002160 Reported : 30/Jun/2023 02:04PM
Visit ID : DSDYOPV1187 Status : Final Report
Ref Doctor : DR RUPASHREE DASGUPTA Client Name : PUP 24X7_CREDIT
IP/OP NO : Patient location : UTTAR PALLY,Kolkata

DEPARTMENT OF IMMUNOLOGY

Test Name Result Status Unit Bio. Ref. Range Method

INSULIN (FASTING) , SERUM 11.91 Normal µIU/mL 1.9-23 CLIA

Comment:
This test is useful in the diagnosis of insulinoma and fasting hypoglycemia. Secretion is regulated primarily by blood glucose levels;
therefore, it should be measured with concomitant blood glucose. Circulating anti-insulin antibodies are often found in patients who
have been treated with nonhuman forms of insulin. If present, these antibodies may interfere with the assay. For individuals who
are significantly overweight, fasting insulin levels are typically somewhat higher
than for adults of normal weight

Page 3 of 4

SIN No:IM05726413
Patient Name : Ms.RINKI DEY Collected : 30/Jun/2023 07:29AM
Age/Gender : 31 Y 3 M 10 D /F Received : 01/Jul/2023 08:48AM
UHID/MR No : DPTI.0000002160 Reported : 01/Jul/2023 10:00AM
Visit ID : DSDYOPV1187 Status : Final Report
Ref Doctor : DR RUPASHREE DASGUPTA Client Name : PUP 24X7_CREDIT
IP/OP NO : Patient location : UTTAR PALLY,Kolkata

DEPARTMENT OF IMMUNOLOGY

Test Name Result Status Unit Bio. Ref. Range Method

FREE ANDROGEN INDEX (FAI) , SERUM
TESTOSTERONE, TOTAL 33.88 Normal ng/dL 11-56 CLIA
SEX HORMONE BINDING 41.10 Normal nmol/L 18.2-135.5 CLIA
GLOBULIN (SHBG)
FREE ANDROGEN INDEX (FAI) 2.86

Comment:
Free Androgen index (FAI) is used as a surrogate marker for androgen status, and best interpreted along with other markers of
androgen status such as Free testosterone, SHBG, total testosterone and gonadotropins. FAI correlates well with Free
testosterone in women and in men it is affected by changes in SHBG and fluctuations of total testosterone based on circadian
rhythm.
In non-obese, non-hirsute oligomenorrheic women, an elevated AI during the early follicular phase is reported to be a sensitive
and specific indicator of Polycystic ovarian disease (PCOD).

*** End Of Report ***

Page 4 of 4

SIN No:IM05729855
This test has been performed at Apollo Health & Lifestyle Ltd, Global Reference Laboratory,Hyderabad